End of the Program
Demystifying Long COVID International Conference 2024
Related Enduring Materials
Enduring Materials
Thursday, 21 November
Opening & Welcome - 14:00
14:10 CET
Opening Talk: Long COVID: State of the Science and Directions for Policy and Research
Session 1: Clinical Spectrum - Different Faces of Long COVID -
14:40 CET
Epidemiology and Long Term Evolution of Long COVID
Olivier Robineau, MD, PhD
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, France
15:05 CET
Autonomic Dysfunction in long COVID
15:30 CET
Long COVID in Children
Session 2: Abstract-Driven Session -
16:55 CET
#3 - Long COVID and Associated Outcomes Following COVID-19 Reinfections: Insights from an International Patient-Led Survey
Session 3: Patient-Centred Coordination of Care - Where Do We Stand? -
17:20 CET
Dutch Example
Mischa Huson, MD, PhD, DTM&H
Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands
17:30 CET
Spanish Example
17:40 CET
French Example
Friday, 22 November
Session 4: Pathophysiology -
08:30 CET
Immune Dysregulation and Autoimmunity in Long COVID
08:55 CET
Viral Reservoirs and Consequences of SARS-CoV-2 Persistence
09:20 CET
#5 - Persistent Immune Dysregulation and Metabolic Alterations Following SARS-CoV-2 Infection
Irini Sereti
United States
Session 5: Diagnostics, Biomarkers, and End Points -
10:20 CET
Molecular PET imaging of long COVID
Eric Guedj, MD, Dipl.-Ing, PhD
Aix-Marseille University / Timone Hospital / Fresnel Institute, France
10:45 CET
Tomorrow, and Tomorrow, and Tomorrow... Studies of the Neuropathogenesis of Long COVID
11:10 CET
#8 - Normalization of Cognitive Function in Patients With Neurological Symptoms Post COVID-19 After 12 Months
Siv Elin Pignatiello
Norway
11:22 CET
#9 - Plasma Biomarkers in Children and Young People With Long COVID
Jon Izquierdo-Pujol
Spain
Session 6: Illustrating the Challenges - Clinical Case Presentations -
13:35 CET
Case 1: Differential Diagnosis
14:00 CET
Case 2: No Cure, What Are the Options
Session 7: Clinical Trials - Prevention and Treatment Options on the Horizon -
14:55 CET
Long Covid Therapeutic Trials: Current Status
15:20 CET
What Have We Learned from Observational Studies to Improve Future Clinical Trials
15:45 CET
Viral Persistence and Long COVID: Lessons Learned from the First Round of Clinical Trials
16:35 CET
Patient Perspective on Clinical Trials Design
Overview
Committees
Support
Symposium
Previous Editions
Endorsers
Accreditation